Sirnaomics Licenses Polypeptide Nanoparticle Technology for Its siRNA Therapeutic Product Development

Sirnaomics, Inc. announced today that the company has licensed a polypeptide nanoparticle technology invented by Professor A. James Mixson of University of Maryland Medical School.

Related Posts

Comments are closed.